Karen M. Anderson sold $2.1M of Centessa Pharmaceuticals (CNTA)

Executed Mar 16, disclosed Mar 18, 2 days later.

Value, as filed

$2.1M

74,811 sh across 2 lots

Executed

Mar 16

the trade date, as filed

Disclosed

Mar 18

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KA Karen M. Anderson Chief People Officer profile →

Karen M. Anderson (Chief People Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Centessa Pharmaceuticals plc (CNTA). The largest single filing was $3.2M of CNTA (120,029 sh across 2 lots, as filed), executed Mar 13.

The name

CNTA Centessa Pharmaceuticals plc CNTA · Healthcare · 56 filings in 24 months ticker →

Healthcare · Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in t…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Karen M. Anderson in CNTA

CNTASALE Centessa Pharmaceuticals plc $1.2M
41,076 sh × $30.12
Exec Mar 26
Filed Mar 27 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc $3.2M
120,029 sh across 2 lots
Exec Mar 13
Filed Mar 13 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc $3.2M
120,029 sh across 2 lots
Exec Mar 13
Filed Mar 16 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc $581K
30,526 sh × $19.03
Exec Feb 7 2025
Filed Feb 10 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc $109K
6,471 sh × $16.86
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc $184K
10,624 sh × $17.32
Exec Dec 17 2024
Filed Dec 17 2024 · 5:30 PM ET